Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorUniversity of Southern California

About this trial

The fluctuating concentrations of female sex hormones, namely estrogen and progesterone may have an effect on the ability of the tissue to withstand challenging exercise conditions, such as eccentric exercise. These sex hormones have also been purported to influence the perceived difficulty of exercise. This study aims to uncover how the different estrogen and progesterone concentrations present throughout the menstrual cycle effect perceived readiness to perform, perceptions of difficulty, and different recovery metrics.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18-35 years of age

BMI of 18.5-29.9 as a BMI below or above these cut points results in highly varied menstrual cycle lengths [15]

Not taking contraception or other types of medication that could influence reproductive status

Regular menstruation

Disqualifiers

Amenorrhea or oligomenorrhea

Perimenopausal or menopausal

Recreational or professional trail or downhill runner

On a form of contraception

Trial design

Design model

Parallel

Treatments tested in this trial

  • Eccentric leg extension

    Behavioral

    Participants will complete a 10 x 10 eccentric leg extension on a Cybex Norm dynamometer. Upon arrival, participants will be asked their perceived readiness to perform on a 11 point numeric rating scale. Before the running protocol a baseline blood sample will be collected, as well as passive and active delayed onset muscle soreness (DOMS), a countermovement jump. Half way through each set (i.e., after the 5th repetition) participants will be asked to rank their level of difficulty on a 11 point OMNI Res scale. This will occur during each set. Participants will have follow up blood draws, measures of muscle function (i.e, jump height) and soreness measured immediately after and 24 and 48 hours post-exercise.

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: Low estrogen; low progesteroneExperimental treatment 1 intervention
Group B: High estrogen; low progesteroneExperimental treatment 1 intervention
Group C: Medium estrogen; high progesteroneExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Preparedness to perform

Perceived readiness will be measured on an 11 point numeric rating scale (NRS) with 0 being not ready at all, and 10 being most prepared

Time frame
Pre exercise
2

Rating of difficulty

Perceived difficulty will be measured on a 11 point numeric rating scale called the OMNI res throughout the duration of exercise.

Time frame
30 minutes
3

Inflammatory markers

Inflammatory markers (IL-6, IL-8, TNF-alpha, and IL-10) will be measured in blood serum to understand how the concentration of estrogen changes the inflammatory response to damaging exercise.

Time frame
Change over time (pre/post, 24 hour, 48 hour)
4

Counter movement jump height

A countermovement jump (CMJ) will be performed on VALD ForceDecks to determine muscle function overtime.

Time frame
Change over time (pre/post, 24 hour, 48 hour)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.